Whitehawk Therapeutics (WHWK) FCF Margin (2018 - 2025)
Whitehawk Therapeutics (WHWK) reported FCF Margin of 173.76% for Q1 2025, up 20719.0% year-over-year from N/an in Q1 2024, and up 14.65% on a QoQ basis from 203.59% in Q4 2024.
Whitehawk Therapeutics (WHWK) has 7 years of FCF Margin data on file, last reported at 173.76% in Q1 2025.
- Quarterly FCF Margin rose 20719.0% year-over-year to 173.76% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 1371.38% (down 113775.0% YoY) and the FY2025 annual result came in at 1371.38%, down 113775.0% from the prior year.
- FCF Margin advanced to 173.76% in Q1 2025 per WHWK's latest filing, from 203.59% in the prior quarter.
- Across five years, FCF Margin topped out at 8802.5% in Q1 2021 and bottomed at 842.57% in Q1 2022.
- The 5-year median for FCF Margin is 213.31% (2023), against an average of 330.53%.
- The widest annual swing landed in 2022, when FCF Margin plunged 964507 bps; it then surged 47275 bps in 2023.
- Tracing WHWK's FCF Margin over 5 years: stood at 88.77% in 2021, then plunged by 145 bps to 217.87% in 2022, then gained by 2 bps to 213.31% in 2023, then climbed by 5 bps to 203.59% in 2024, then increased by 15 bps to 173.76% in 2025.
- Per Business Quant, the three latest WHWK FCF Margin figures stand at 173.76% (Q1 2025), 203.59% (Q4 2024), and 229.67% (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -173.76% |
| Dec 31, 2024 | -203.59% |
| Sep 30, 2024 | -229.67% |
| Jun 30, 2024 | -145.80% |
| Mar 31, 2024 | -380.95% |
| Dec 31, 2023 | -213.31% |
| Sep 30, 2023 | -168.07% |
| Jun 30, 2023 | -297.15% |
| Mar 31, 2023 | -369.81% |
| Dec 31, 2022 | -217.87% |
| Sep 30, 2022 | -200.47% |
| Jun 30, 2022 | -312.71% |
| Mar 31, 2022 | -842.57% |
| Dec 31, 2021 | -88.77% |
| Mar 31, 2021 | 8,802.50% |
| Dec 31, 2020 | -23.39% |
| Sep 30, 2020 | -6,833.24% |
| Jun 30, 2020 | 68.61% |
| Dec 31, 2018 | -288,868.14% |
| Sep 30, 2018 | -33.17% |
| Jun 30, 2018 | 983.43% |